Systematic pan-cancer analysis identifies RALA as a tumor targeting immune therapeutic and prognostic marker
IntroductionRALA is a member of the small GTPase Ras superfamily and has been shown to play a role in promoting cell proliferation and migration in most tumors, and increase the resistance of anticancer drugs such as imatinib and cisplatin. Although many literatures have studied the cancer-promoting...
Main Authors: | Haoer Jin, Sha Qin, Jiang He, Juxiong Xiao, Qingling Li, Yitao Mao, Luqing Zhao |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-11-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2022.1046044/full |
Similar Items
-
The RAL Enigma: Distinct Roles of RALA and RALB in Cancer
by: Dillon S. Richardson, et al.
Published: (2022-05-01) -
Dissolving microneedles for DNA vaccination: Improving functionality via polymer characterization and RALA complexation
by: Grace Cole, et al.
Published: (2017-01-01) -
Improving the Intercellular Uptake and Osteogenic Potency of Calcium Phosphate via Nanocomplexation with the RALA Peptide
by: Michelle O’Doherty, et al.
Published: (2020-12-01) -
Systematic analysis of the role of LDHs subtype in pan-cancer demonstrates the importance of LDHD in the prognosis of hepatocellular carcinoma patients
by: Shengnan Wang, et al.
Published: (2024-01-01) -
Elevated RalA activity in the hippocampus of PI3Kγ knock-out mice lacking NMDAR-dependent long-term depression
by: Su-Eon Sim, et al.
Published: (2013-02-01)